News | November 10, 2021
Pulmatrix resolves dispute with Cipla
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The new facility will provide an important boost to vaccine capacity in Africa
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The company is a medical dictation solution used by medical practitioners
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
It recommends using the vaccine to prevent the spread of the disease
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
Subscribe To Our Newsletter & Stay Updated
